JANSSEN RESEARCH & ) DEVELOPMENT LLC / BAYER PHARMA AG / AND JOHNSON PHARMACEUTICALS / Defendant JANSSEN RESEARCH & DEVELOPMENT LLC / RESEARCH AND DEVELOPMENT LLC / Schering AG / JANSSEN PHARM / BAYER HEALTHCARE PHARMACEUTICALS INC. / Schering Berlin Inc. / Defendant JANSSEN PHARMACEUTICALS INC. / Defendant BAYER PHARMA AG / JOHNSON & JOHNSON COMPANY / Berlex Laboratories Inc. / Berlex Inc. / JANSSEN ORTHO LLC / JANSSEN PHARMACEUTICA INC. / 46 Healthcare PHARMACEUTICALS Inc. / PHARMACEUTICALS INC. / Bayer Healthcare LLC / McNeilJanssen PHARMACEUTICALS Inc. / Defendant BAYER AG / Defendants BAYER CORPORATION / HEALTHCARE PHARMACEUTICALS / BAYER AG / Defendant BAYER CORPORATION / MCNEIL-JANSSEN PHARMACEUTICALS INC. / Defendants Janssen Research & Development LLC / Bayer Schering Phanna AG / 46 BAYER CORPORATION / HEALTHCARE LLC / Bayer Schering Pharma AG / Janssen PHARMACEUTICALS Inc. / /
Country
Germany / Puerto Rico / United States / /
Currency
USD / /
Event
Name Change / /
Facility
One Johnson & Johnson Plaza / /
IndustryTerm
pharmaceutical / manufacturing / chemical / pharmaceutical products / /
MedicalCondition
systemic embolism / hemorrhagic stroke / stroke / pain / non-valvular atrial fibrillation / severe and permanent personal injuries / injuries / /
MedicalTreatment
hip and knee replacement surgery / replacement surgery / /
Person
JOHN DOES / ANN PECK / FALLON MAG / FRANK PECK / /
Position
undersigned counsel / JUDGE / /
Product
Xarelto / /
ProvinceOrState
New Jersey / New Brunswick / Prince Edward Island / Indiana / Middlesex County / Pennsylvania / Oklahoma / Delaware / New / Idaho / /
Case 2:15-cvDocument 1 FiledPage 1 of 46 UNITED STATES DISTRICT COURT EASTERN DISTRICT OF LOUISIANA IN RE: XARELTO (RIVAROXABAN)